Transcriptional up-regulation of PHLDA1 by 17β-estradiol in MCF-7 breast cancer cells

Brazilian Journal of Medical and Biological Research

Volumn 41, Issue 7, 2008, Pages 579-582

  Marchiori, A C ^a   Casolari, D A ^a   Nagai, M A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Breast cancer; Estrogen receptor; Estrogen response elements; Gene expression; PHLDA1

Indexed keywords

CHROMOSOME PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; MESSENGER RNA; PHLDA1 PROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; PROMOTER REGION; UPREGULATION;

EID: 52949137042     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2008005000029     Document Type: Article

References (20)

1. Russo IH, Russo J. Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 1998; 3: 49-61.
2. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, et al. Mechanisms of estrogen action. Physiol Rev 2001; 81: 1535-1565.
3. Hall JM, McDonnell DP. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ER-alpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999; 140: 5566-5578.
4. Gruber CJ, Gruber DM, Gruber IM, Wieser F, Huber JC. Anatomy of the estrogen response element. Trends Endocrinol Metab 2004; 15: 73-78.
5. Kushner PJ, Agard D, Feng WJ, Lopez G, Schiau A, Uht R, et al. Oestrogen receptor function at classical and alternative response elements. Novartis Foundation Symposium. Chichester, New York: Wiley; 2000; 230: 20-26.
6. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005; 122: 33-43.
7. Bourdeau V, Deschenes J, Metivier R, Nagai Y, Nguyen D, Bretschneider N, et al. Genome-wide identification of highaffinity estrogen response elements in human and mouse. Mol Endocrinol 2004; 18: 1411-1427.
8. Ring A, Dowsett M. Mechanisms of tamoxifen resistance. Endocr Relat Cancer 2004; 11: 643-658.
9. Nagai MA, Ros N, Bessa SA, Mourao NM, Miracca EC, Brentani MM. Differentially expressed genes and estrogen receptor status in breast cancer. Int J Oncol 2003; 23: 1425-1430.
10. Kuske MD, Johnson JP. Assignment of the human PHLDA1 gene to chromosome 12q15 by radiation hybrid mapping. Cytogenet Cell Genet 2000; 89: 1.
11. Park CG, Lee SY, Kandala G, Lee SY, Choi Y. A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. Immunity 1996; 4: 583-591.
12. Gomes I, Xiong W, Miki T, Rosner MR. A proline- and glutamine-rich protein promotes apoptosis in neuronal cells. J Neurochem 1999; 73: 612-622.
13. Neef R, Kuske MA, Prols E, Johnson JP. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Cancer Res 2002; 62: 5920-5929.
14. Nagai MA, Fregnani JH, Netto MM, Brentani MM, Soares FA. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression. Breast Cancer Res Treat 2007; 106: 49-56.
15. De Bessa SA, Salaorni S, Patrao DF, Neto MM, Brentani MM, Nagai MA. JDP1 (DNAJC12/Hsp40) expression in breast cancer and its association with estrogen receptor status. Int J Mol Med 2006; 17: 363-367.
16. Lewis JS, Jordan VC. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Mutat Res 2005; 591: 247-263.
17. Nagai MA, Brentani MM. Gene expression profiles in breast cancer to identify estrogen receptor target genes. Mini Rev Med Chem 2008; 8: 448-454.
18. Anderson I, Gorski J. Estrogen receptor alpha interaction with estrogen response element half-sites from the rat prolactin gene. Biochemistry 2000; 39: 3842-3847.
19. O'Lone R, Frith MC, Karlsson EK, Hansen U. Genomic targets of nuclear estrogen receptors. Mol Endocrinol 2004; 18: 1859-1875.
20. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516.